Mendor raises 8.1 Million in a Series B financing round for global market expansion

  • Share on Twitter
  • Share on LinkedIn

Mendor, a leading company in new diabetes technologies and services, announces 8.1 Million of Venture Capital financing to facilitate its global market expansion. The series-B financing round was led by the Finnish entrepreneur and investor Risto Siilasmaa, joined by Life Sciences Partners (LSP), Finnish Industry Investment Ltd, Finnish Mutual Pension Insurance Company Ilmarinen, private Finnish investment group Biothom and the Finnvera Venture Capital as a returning investor.

Founded in 2006 in Helsinki, Finland, Mendor designs, develops and markets innovative diabetes care products and services. Mendor’s first product, the all-in-one blood glucose meter Discreet™, has received high praise from clinicians and diabetologists all over the world. The meter contains all the necessary components for daily blood glucose measurements: meter, strips and lancing device in an integrated, all-in-one device the size of a cell phone. Mendor Discreet™ is designed to simplify the lives of people with diabetes who regularly need to test their blood glucose levels.

The Mendor Balance™ application is a next generation web-based software that supports the Discreet™ meter. The system can be accessed anywhere once the data have been uploaded allowing diabetes patients to take control of their condition by providing a thorough analysis of their treatment. Pair measurements before and after meals and sleep help to determine problem areas and means that patients are able to manage their diabetes more effectively.

Mendor brand video available at

Kristian Ranta, Mendor CEO and Co-Founder commented, “We are very happy to have such great investors joining the investment round and helping us facilitate better self-care for diabetics all over the world with Mendor’s innovative and ground breaking products and services. Mendor is facing strong growth in the upcoming years and a solid financial base will help us tremendously in achieving our targets.”

Following the closing of the financing round Anne Portwich, PhD (Partner, LSP), will be joining the board of directors of Mendor.

Recently Mendor was selected as a Red Herring Europe top 100 technology start-up.

More information from:

Further information:

Kristian Ranta, CEO, Co-Founder, Mendor
Mobile: +358 45 673 3313
E-mail: kristian.ranta (at)

Mendor home page:
Mendor on Twitter:
Mendor on facebook:

Jussi Hattula, Investment Director, Finnish Industry Investment Ltd
Mobile: +358 400 669 955
E-mail: jussi.hattula (at)


About Risto Siilasmaa
Risto Siilasmaa is the founder of F-Secure Corporation. He served as the President and CEO of the company 1988-2006. He is the Chairman of the Board of Directors of F-Secure (since 2006), Elisa Corporation (since 2008) and Fruugo Inc. (since 2007).

About LSP
Life Sciences Parnters (LSP) is a leading independent European investment firm, providing financing for private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. For example, LSP was a founding investor in Movetis, Crucell, DNage, Qiagen, Rhein Biotech and Pharming. With over EUR 500 million under management and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors.

About Ilmarinen
Ilmarinen Mutual Pension Insurance Company is responsible for the statutory earnings-related pension security of employees and self-employed persons and the investment assets that cover future pensions. In 2010, Ilmarinen’s premiums written totalled EUR 3.4 billion and the company paid out EUR 3.3 billion in pensions. The value of assets totalled EUR 28.1 billion at the end of 2010. Ilmarinen is responsible for the pension cover of 850,000 people. The company’s share of the market is about one third. More information at

About Finnish Industry Investment Ltd
Finnish Industry Investment Ltd is a government-owned investment company. Its mission is to promote Finnish business, job creation and economic growth through venture capital and private equity investments. Finnish Industry Investment invests in funds and directly in growth companies in all sectors. The investment focus is on growth, internationalization, spin-offs, major industrial investments, as well as sectoral and corporate restructurings. Finnish Industry Investment collaborates closely with other investors and always invests together with private co-investors. With over €670m of capital under management, Finnish Industry Investment’s portfolio consists of around 90 fund investments and 75 direct investments.

About Biothom
Biothom Oy, located in Helsinki, invests into companies representing various areas of Life Sciences and has interests in young, innovative companies in the United States, Finland and Sweden. Biothom is a member of Thominvest Group, a privatively held Finnish investment firm.